DESANTIS, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 2.305
AS - Asia 1.379
EU - Europa 868
SA - Sud America 414
AF - Africa 76
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.048
Nazione #
US - Stati Uniti d'America 2.228
SG - Singapore 616
BR - Brasile 369
CN - Cina 278
IT - Italia 199
HK - Hong Kong 181
RU - Federazione Russa 165
SE - Svezia 130
VN - Vietnam 129
DE - Germania 115
GB - Regno Unito 64
FR - Francia 50
CA - Canada 43
IN - India 32
CI - Costa d'Avorio 31
ID - Indonesia 29
FI - Finlandia 28
MX - Messico 22
NL - Olanda 22
ZA - Sudafrica 21
ES - Italia 20
AR - Argentina 18
PL - Polonia 18
IQ - Iraq 13
JP - Giappone 13
TR - Turchia 13
AT - Austria 12
BD - Bangladesh 12
LT - Lituania 10
AE - Emirati Arabi Uniti 8
VE - Venezuela 8
BE - Belgio 6
EC - Ecuador 6
JO - Giordania 6
UZ - Uzbekistan 6
AU - Australia 5
CH - Svizzera 5
CL - Cile 5
MA - Marocco 5
SA - Arabia Saudita 5
UA - Ucraina 5
EG - Egitto 4
KE - Kenya 4
KR - Corea 4
PH - Filippine 4
PK - Pakistan 4
CO - Colombia 3
DK - Danimarca 3
IR - Iran 3
OM - Oman 3
PY - Paraguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BS - Bahamas 1
CD - Congo 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
GM - Gambi 1
GT - Guatemala 1
HT - Haiti 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MG - Madagascar 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 5.048
Città #
Ashburn 392
Singapore 321
Chandler 208
Hong Kong 177
Fairfield 172
Woodbridge 131
Nyköping 114
Beijing 113
New York 91
Seattle 84
Cambridge 81
Los Angeles 76
Houston 71
Bari 69
Wilmington 65
Ann Arbor 60
Dallas 52
Munich 47
Ho Chi Minh City 41
São Paulo 39
Abidjan 31
Jakarta 27
Lawrence 26
Roxbury 26
Brooklyn 24
Hanoi 22
Chicago 21
Dearborn 19
Falkenstein 19
Frankfurt am Main 19
Nanjing 19
Rome 19
Inglewood 18
Chennai 17
Des Moines 17
Dong Ket 17
Johannesburg 17
Buffalo 15
Helsinki 15
Toronto 15
Denver 14
London 14
Montreal 14
Moscow 14
Curitiba 13
Orem 13
Phoenix 13
Rio de Janeiro 13
Santa Clara 13
Tokyo 13
Warsaw 12
Haiphong 11
Marseille 11
Poplar 11
San Diego 11
Boston 10
Grafing 10
Campinas 9
Manchester 9
San Jose 9
Washington 9
Nuremberg 8
Princeton 8
Stockholm 8
Guangzhou 7
Guarulhos 7
Hebei 7
Mexico City 7
Paris 7
Turku 7
Amman 6
Ankara 6
Atlanta 6
Baghdad 6
Brussels 6
Goiânia 6
Porto Alegre 6
The Dalles 6
Amsterdam 5
Belo Horizonte 5
Boardman 5
Brasília 5
Buenos Aires 5
Da Nang 5
Jacksonville 5
Jinan 5
Manaus 5
Pune 5
Roubaix 5
Augusta 4
Biên Hòa 4
Brescia 4
Canoas 4
Changsha 4
Columbus 4
Council Bluffs 4
Dhaka 4
Düsseldorf 4
Florence 4
Lahore 4
Totale 3.266
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 197
Isolation and characterization of neural stem cells from dystrophic mdx mouse 191
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 172
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 165
Microenvironment drug resistance in multiple myeloma: Emerging new players 158
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 155
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 151
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 140
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 140
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 137
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 137
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 126
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 123
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 120
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 112
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 112
Erratum: Corrigendum to “Isolation and characterization of neural stem cells from dystrophic mdx mouse” (Experimental Cell Research (2016) 343(1) (190–207) (S0014482716300593) (10.1016/j.yexcr.2016.03.019)) 110
Diabetes and alzheimer’s disease: Might mitochondrial dysfunction help deciphering the common path? 98
The role of SIRT6 in tumors 89
ROLE OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND CORRELATION WITH VASCULAR STIFFNESS AND ORGAN DAMAGE 87
Two-year follow-up after drug desensitization in mucopolysaccharidosis 87
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 86
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 84
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 84
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress 84
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 83
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 82
A Challenging Case of Visceral Leishmaniasis 81
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 80
Antiangiogenic drugs as chemosensitizers in hematological tumors 78
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 73
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 73
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 71
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 68
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 67
Genomic profiling at a single center cracks the code in inborn errors of immunity 66
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 65
Epigenetic regulation of angiogenesis in tumor progression 64
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 63
Changes in Lipids in Granulomatosis with Polyangiitis Relates to Glucocorticoids and History of Hypertension 61
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 60
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 59
IMPACT OF REMOTE MONITORING ON PATIENTS’ QUALITY OF LIFE. A SINGLE CENTRE STUDY 58
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 56
Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation. 52
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 52
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 52
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments 52
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 50
Correlation between atrial cardiomyopathy and predictive biomarkers of cryptogenic stroke in primary and secondary prophylaxis: potential role of endothelial progenitor cell (EPCs) dysfunction 49
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation 49
Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview 46
GENDER DISPARITIES IN HYPERTENSIVE PATIENTS ACROSS THE LIFETIME: AN AGE-STRATIFIED ANALYSIS 43
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value 39
null 39
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 38
How to manage hypersensitivity reactions to enzyme replacement therapy in lysosomal storage diseases? 38
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective Studies 37
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 37
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 36
Mast Cells and Interleukins 32
Visualizing the Interactions Shaping the Imaging of the Microenvironment in Human Cancers 32
Successful rapid desensitization to zoledronic acid in a multiple myeloma patient 28
Spatial imaging unlocks the potential of charting multiple myeloma and extramedullary disease 26
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature 24
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma 21
Tunneling nanotubes between bone marrow stromal cells support transmitophagy and resistance to apoptosis in myeloma 20
Progressive NK Cell Dysfunction and ILC Imbalance Favor Immune Evasion in Multiple Myeloma 13
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrum 12
Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment Horizons 9
Totale 5.379
Categoria #
all - tutte 24.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 0 29 47 33 30 56 29 34
2021/2022252 11 18 4 10 8 17 14 11 19 26 38 76
2022/2023454 43 78 38 46 35 63 9 56 65 10 9 2
2023/2024277 19 27 17 23 31 105 7 8 0 17 6 17
2024/20251.457 50 24 43 48 52 131 280 153 78 92 177 329
2025/20261.872 457 165 226 380 466 178 0 0 0 0 0 0
Totale 5.379